Clinical studies assessing the safety of ASNase demonstrated that adult ALL patients can develop elevations in serum biomarkers of liver injury, such as alanine aminotransferase (ALT) via an unknown mechanism.4 The gene discussed is GPT; the disease is acute lymphoblastic leukemia.